Acta Vet. Brno 2019, 88: 225-232
https://doi.org/10.2754/avb201988020225
The effect of triamcinolone in liposomes on oral wound healing in rats
References
1. 1984: Novel concept for a mucosal adhesive ointment. J Pharm Sci 73: 548-552
< KD, Strempel H, Klein G https://doi.org/10.1002/jps.2600730429>
2. 2003: The role of nitric oxide in oral diseases. Arch Oral Biol 48: 93-100
< PA, Thomas GJ, Langdon JD https://doi.org/10.1016/S0003-9969(02)00183-8>
3. 1988: Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm 14: 283-318
< DE, Touchard F, Pappas NA https://doi.org/10.3109/03639048809151972>
4. 2006: In vivo study of liposomes as drug carriers to oral mucosa using EPR oximetry. Int J Pharm 307: 1-8
< V, Pavlica Z, Sentjurc M, Petelin M https://doi.org/10.1016/j.ijpharm.2005.09.016>
5. 2006: Triamcinolone acetonide mouth rinses for treatment of erosive oral lichen planus: efficacy and risk of fungal over–infection. Oral Dis 12: 559-565
< A, Diniz-Freitas M, Gandara-Vila P, Blanco-Carrion A, Garcia-Garcia A, Gandara-Rey J https://doi.org/10.1111/j.1601-0825.2006.01238.x>
6. 2010: The use of topical corticoids in oral pathology. Med Oral Patol Oral Cir Bucal 15: e827-e8231
< MA https://doi.org/10.4317/medoral.15.e827>
7. 2002a: Clobetasol mouthwash is effective for severe oral erosive lesions. Dent Abstr 47: 268
MA, Morales-Garcia P, Rodriguez-Archilla A
8. 2002b: Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93: 264-270
< MA, Morales P, Rodriguez-Archilla A, Isabel IR, Gonzalez-Moles S https://doi.org/10.1067/moe.2002.120522>
9. 2003: Treatment of severe erosive gingival lesions by topical application of clobetasol propionate in custom trays. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 688-692
< MA, Ruiz-Avila I, Rodriguez-Archilla A, Morales-Garcia P, Mesa-Aguado F, Bascones-Martinez A, Bravo M https://doi.org/10.1067/moe.2003.139>
10. 2005a: Vesiculo-erosive oral mucosal disease management with topical corticosteroids: (1) fundamental principles and specific agents available. J Dent Res 84: 294-301
< MA, Scully C https://doi.org/10.1177/154405910508400401>
11. 2005b: Vesiculo-erosive oral mucosal disease management with topical corticosteroids: (2) Protocols, monitoring of effects and adverse reactions, and the future. J Dent Res 84: 302-308
< MA, Scully C https://doi.org/10.1177/154405910508400402>
12. 1994: Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 5: 78-111
< AD, Socransky SS https://doi.org/10.1111/j.1600-0757.1994.tb00020.x>
13. 1986. Liposomes as drug carriers for oral ulcers. J Dent Res 65: 1133-1141
< BB, Hilchie JC, Mezei M https://doi.org/10.1177/00220345860650090501>
14. 2008: iNOS expression in oral and gastrointestinal tract mucosa. Dig Dis Sci 53: 1437-1442
< N, Koray M, Kocaelli H, Akinci S https://doi.org/10.1007/s10620-007-0061-5>
15. 2003: Skin oxygenation after topical application of liposome–entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size. AAPS Pharm Sci 5: 19-27
< J, Abramovic Z, Sentjurc M https://doi.org/10.1208/ps050102>
16. 2001: Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivo. J Control Release 70: 203-211
< M, Sentjurc M, Kristl J https://doi.org/10.1016/S0168-3659(00)00351-5>
17. 2000: Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 35: 369-373
< DF, Kjeldsen M, Sander L, Kinane DF https://doi.org/10.1034/j.1600-0765.2000.035006369.x>
18. Little JW, Miller CS, Rhodus NL, Falace D (Eds) 2002: Dental Management of the Medically Compromised Patient. 6th edn. St. Louis, Mosby.
19. 1998: Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature–induced periodontitis in the rat. Br J Pharmacol. 123: 353-360. Erratum in: Br J Pharmacol 123: 741
< Z, Benedek P, Fehér E, Györfi A, Rosivall L, Fazekas A, Salzman AL, Szabó C https://doi.org/10.1038/sj.bjp.0701604>
20. 2001: Evidence for reactive nitrogen species formation in the gingivomucosal tissue. J Dent Res 80: 470-475
< Z, Stachlewitz R, Virag L, Szekely AD, Hasko G, Szabó C https://doi.org/10.1177/00220345010800021401>
21. 1991: Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 71: 283-287
< F, Huang MZ, Zhou GA https://doi.org/10.1016/0030-4220(91)90300-2>
22. 1997: Oral lichen planus: topical and systemic therapy. Semin Cutan Med Surg 16: 295-300
< F, Miranda C https://doi.org/10.1016/S1085-5629(97)80019-3>
23. 1994: Double-blind clinical trial of 0.05% clobetasol propionate ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 77: 598-604
< F, Miranda C, Maliksi R https://doi.org/10.1016/0030-4220(94)90318-2>
24. 1984. Adverse side effects associated with prednisone in the treatment of patients with oral inflammatory ulcerative diseases. J Am Dent Assoc 109: 269-270
< F, Silverman S Jr, Migliorati C https://doi.org/10.14219/jada.archive.1984.0349>
25. 1982: Liposomes: a selective drug delivery system for the topical route of administration. Gel dosage form. J Pharm Pharmacol 34: 473-474
< M, Gulasekharam V https://doi.org/10.1111/j.2042-7158.1982.tb04767.x>
26. 1993. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
S, Higgs A
27. 2005: Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 105: 240-248
< JA, Reed BL, Finnin BC https://doi.org/10.1016/j.jconrel.2005.03.022>
28. 1998: EPR study of mucoadhesive ointments for delivery of liposomes into the oral mucosa. Int J Pharm 173: 193-202
< M, Sentjurc M, Stolic Z, Skaleric U https://doi.org/10.1016/S0378-5173(98)00232-4>
29. 1998: Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9: 86-122
< C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, Holmstrup P, Mutlu S, Porter S, Wray D https://doi.org/10.1177/10454411980090010501>
30. 1999: Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. J Control Release 59: 87-97
< M, Vrhovnik K, Kristl J https://doi.org/10.1016/S0168-3659(98)00181-3>
31. 1975: Corticosteroid therapy. J Am Med Assoc 232: 944-948
< DH, Phil D https://doi.org/10.1001/jama.1975.03250090034016>
32. 1993: Oral mucosal adhesive ointment containing liposomal corticosteroid. Int J Pharm 95: 105-109
< SJ, Holbrook WP https://doi.org/10.1016/0378-5173(93)90396-W>
33. Ten Cate AR 1998: Oral histology: development, structure, and function. St. Louis: Mosby Year Book, pp. 345-385
34. 2003: The role of acquired immunity and periodontal disease progression. Crit Res Oral Biol Med 14: 237-252
< YT https://doi.org/10.1177/154411130301400402>
35. 1994: Topical corticosteroids and lesions of the oral mucosa. Adv Drug Delivery Rev 13: 135-149
< DN, Ferguson MM https://doi.org/10.1016/0169-409X(94)90030-2>
36. 1990: Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 70: 165-171
< SD, Baker KA, Williams TP https://doi.org/10.1016/0030-4220(90)90112-6>